R&D

Japanese pharma company Eisai has granted exclusive development and marketing rights for lorcaserin hydrochloride, its anti-obesity agent, to Brazil’s Eurofarma Laboratórios. Lorcasrin, a generic of...

Chicago healthcare company Abbott has named Robert B. Ford as its new President and Chief Operating Officer. Mr Ford is a 22-year veteran of Abbot...

Karuna Pharmaceuticals has initiated a Phase 2 study evaluating the efficacy and safety of its lead product candidate, Karuna-Xanomeline-Trospium (KarXT), for treating psychosis in...